R&D Systems™ Recombinant Human RECK Fc Chimera Protein, CF
Measured by its binding ability in a functional ELISA.
Supplier: R&D Systems™ 10309RE050
DescriptionWhen Recombinant Human RECK Fc Chimera is immobilized at 2 µg/mL (100 µL/well), Recombinant Human TEM5/GPR124 His-tag binds with an ED50 of 0.7 to 5.6 µg/mL
|hRECK, membrane-anchored glycoprotein (metastasis and invasion), reversion-inducing-cysteine-rich protein with kazal motifs, ST15, ST15reversion-inducing cysteine-rich protein with Kazal motifs, suppression of tumorigenicity 15 (reversion-inducing-cysteine-rich protein withkazal motifs), suppression of tumorigenicity 5 (reversion-inducing-cysteine-rich protein withkazal motifs), Suppressor of tumorigenicity 15 protein|
Human embryonic kidney cell, HEK293-derived human RECK protein
Human RECK (Met1-Pro941) Accession # O95980IEGRMDHuman IgG1 (Pro100-Lys330)N-terminus C-terminus
|Reconstitute at 500 µg/mL in water.|
|<0.10 EU per 1 µg of the protein by the LAL method.|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.|
|Lyophilized from a 0.2 µm filtered solution in Tris and NaCl.|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok